Endogenous inhibition of CaMKII: A Novel molecular mechanism to terminate memory formation
Endogenous inhibition of CaMKII: A Novel molecular mechanism to terminate memory formation
批准号:
G0800393/1
负责人:
Karl Giese
金额:
$58.64万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2009
资助国家:
英国
项目状态:
已结题
起止时间:
2009 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
What mechanisms are needed to make and store memories in the brain? These mechanisms are still not sufficiently well understood, a fact that prevents us from curing learning and memory deficits in diseases such as mental retardation. My laboratory is studying mechanisms that underlie learning and memory in mice. We perform studies with mice, because in humans we cannot perform well-defined experimental manipulations that are needed to establish mechanisms, and mice are the closest animal species to humans for which a very large repertoire of sophisticated manipulations has been established. We and others have shown that an enzyme called CaMKII is required for the making, but not for the storage, of memory. To terminate the memory making the enzyme needs to be switched off. We have proposed that an endogenous inhibitor protein (CaMKIINalpha) performs this function. More studies are required to validate our hypothesis and here we propose to carry out such studies. If our hypothesis were correct, then follow-up studies will examine whether the novel memory mechanism could be impaired in diseases with associated memory deficits.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Can learning deficits in neurodevelopmental disorders be reversed by restoring gene function in the adult brain?
-
批准号:MR/V013173/1
-
项目类别:Research Grant
-
资助金额:$50.3万
-
财政年份:2021
-
负责人:Karl Giese
-
依托单位:
The Role of Multi-innervated Dendritic Spines in Memory Formation in Ageing
-
批准号:BB/J021423/1
-
项目类别:Research Grant
-
资助金额:$45.61万
-
财政年份:2013
-
负责人:Karl Giese
-
依托单位:
国内基金
海外基金
登录
查看更多内容
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
-
批准号:82370751
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张明
-
依托单位:
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
-
批准号:82372202
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯旭敏
-
依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
基于甲状旁腺素重塑腱骨止点微结构及促软骨和抑瘢痕的机制研究
-
批准号:82372132
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:叶庭均
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
新生期阻断谷氨酸NMDA受体对大鼠感觉运动门控和NRG1-ErbB信号系统的影响
-
批准号:30800361
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2008
-
负责人:苏允爱
-
依托单位:
返回抑制的眼动和注意成分及其神经机制
-
批准号:30770717
-
项目类别:面上项目
-
资助金额:26.0万元
-
批准年份:2007
-
负责人:张明
-
依托单位: